Case report · 16 Aug 2025
PerspectivePublished 27 Oct 2023
Gastric Adenocarcinoma Management: A Perspective
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Gastric Adeno Carcinoma (GAC) remains a formidable global health challenge, marked by its geographical variability and the pressing need for improved therapeutic strategies. This opinion piece aims to delve into recent strides made in GAC management, with a specific focus on the localized and metastatic settings. We explore the details of adjunctive therapy for localized GAC and discuss the promising developments, including immune checkpoint inhibitors, for Microsatellite Instability High (MSI-H) GAC. In the metastatic arena, we survey the evolving realm of targeted therapies and immune checkpoint inhibitors, highlighting the recent approval of trastuzumab deruxtecan for HER-2-positive GAC. We also contemplate the prospects of claudin 18.2 (CLDN18.2) and Fibroblast Growth Factor Receptor (FGFR) as novel therapeutic targets in GAC.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Oncology: Case Reports.
Research article · 30 Jul 2025
A Peculiar Case of Chronic Myelomonocytic Leukemia with Myelodysplastic Syndrome Overlap Presenting with Acute Renal Failure
Case report · 30 Jul 2025
Vertebral Giant Cell Tumor in a Young Male with Early Aggressive Recurrence and Pulmonary Metastases: A Rare Case Report and Literature Review
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Oncology: Case Reports
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Carlos A. Cardenas”
- BylineArticles whose byline prints “Shabnam Abrishami”

